Indeed, the down-regulation of β-catenin leads to a lower expression of matrix metalloproteinase MMP-2, meaning that gal-3 may regulate the Wnt/β-catenin signaling pathway in cancer cells (Figure 3) [60]. The gene discussed is LGALS3; the disease is cancer.